Taysha Gene Therapies (NASDAQ: TSHA) is a patient-centric gene therapy company with a mission to eradicate monogenic CNS disease.
Location: United States
Total raised: $125M
Investors 4
| Date | Name | Website |
| - | PBM Capita... | pbmcap.com |
| - | Octagon Ca... | octagoninv... |
| - | Trinity Ca... | trinitycap... |
| 10.07.2021 | GV | gv.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.08.2020 | Series B | $95M | - |
| 29.04.2020 | Seed | $30M | - |
Mentions in press and media 16
| Date | Title | Description | Source |
| 14.08.2023 | Taysha Gene Therapies Announces $150 Million Private Placeme... | - | tcgcrossov... |
| 26.10.2022 | Vaxcyte's data lead to $600M haul, while Taysha looks to r... | It’s only been a few days since Vaxcyte gave the biotech world a peek at data for its 24-valent ... | endpts.com... |
| 27.01.2022 | Taysha Gene Therapies : Announces Positive Initial Biomarker... | Taysha Gene Therapies Announces Positive Initial Biomarker Data For TSHA-101, the First Bicistronic ... | marketscre... |
| 10.11.2021 | Taysha Gene Therapies Reports Third Quarter 2021 Financial R... | Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update Ant... | marketscre... |
| 05.10.2021 | Taysha Gene Therapies : Announces Exclusive Option from UTSW... | Taysha Announces Exclusive Option from UTSW to License Worldwide Rights to Clinical-Stage AAV9 Gene ... | marketscre... |
| 16.08.2021 | Taysha Gene Therapies, Inc. Secures Up to $100 Million Non-D... | Taysha Gene Therapies, Inc. announced that it has entered into a loan and security agreement with Si... | marketscre... |
| 16.08.2021 | Taysha Gene Therapies : Secures up to $100 Million Non-Dilut... | Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric gene therapy company focused on develo... | marketscre... |
| 09.03.2021 | Taysha Gene Therapies Announces Collaboration to Advance Nex... | DALLAS--(BUSINESS WIRE)--Mar 9, 2021-- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric... | oaoa.com/n... |
| 26.02.2021 | Taysha Gene Therapies Announces Support of Rare Disease Day ... | DALLAS--(BUSINESS WIRE)--Feb 26, 2021-- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centri... | oaoa.com/n... |
| 06.08.2020 | Taysha Gene Therapies Inks $95M Series B | DALLAS, TX, Taysha Gene Therapies announced that it has closed an oversubscribed $95 million Serie... | vcnewsdail... |
Show more